To determine whether engaging pregnant substance abusers in an integrated program of prenatal care and substance abuse treatment would improve neonatal outcomes.
Reports of illicit substance abuse during pregnancy range from 0.4% to 27%; [12] [13] [14] estimates of alcohol and nicotine use are considerably higher. Particularly troublesome is the fact that most substanceabusing patients abuse multiple substances.
Many studies have reported increased rates of pregnancy-related complications and adverse perinatal outcomes for women who have abused substances during pregnancy compared with women who have not. 12, 13, [15] [16] [17] [18] [19] [20] [21] Compelling evidence exists that drug abuse during pregnancy increases the risk of a poor pregnancy outcome. The purpose of this study was to determine whether providing pregnant women with specialized substance abuse treatment, integrated with prenatal care, would result in better neonatal outcomes.
This study describes the experience of Project Link, an intensive outpatient program that integrated specialized substance abuse treatment services with maternal and child health care at Women and Infants Hospital of Rhode Island. We hypothesized that pregnant substance abusers receiving substance abuse treatment in concert with prenatal care would have better neonatal outcomes than pregnant substance abusers who received routine prenatal care but did not receive the substance abuse treatment intervention during pregnancy.
MATERIALS AND METHODS
Project Link was a 5-year, hospital-based, intensive outpatient substance abuse treatment program for pregnant and postpartum women, supported by a demonstration grant from the Center for Substance Abuse Prevention. Project services were available to all women Because randomization of pregnant substance-abusing women to treatment/nontreatment groups was not ethically possible, we chose a research design in which the infants born to women who enrolled in Project Link during pregnancy were compared with those born to women who did not receive Project Link services until after delivery. Study subjects included all women who enrolled in Project Link either prenatally or postpartum and delivered a singleton newborn between May 1, 1992 and December 31, 1995. For those women who enrolled with the project for two pregnancies during the study period, only outcome data from the first pregnancy were used. The study sample consisted of 87 women who enrolled in Project Link while pregnant and 87 women who enrolled postpartum.
Women who enrolled during pregnancy were referred by the prenatal care provider. All women were routinely asked about past and/or present substance abuse as part of the standard prenatal history. If, at the time of the initial history or during any subsequent prenatal visit, a woman admitted to, or was suspected of, illicit substance abuse, a referral was made to Project Link. Project services were explained, and patients who agreed to participate were enrolled. Women who enrolled during pregnancy received a comprehensive package of substance abuse treatment services including individual and group counseling and case management.
Women who enrolled postpartum were referred by staff in the labor and delivery suite or the postpartum inpatient units. Of the 87 postpartum enrollees included in this study, 84 (97%) had been identified during the prenatal period as having a substance abuse problem, but had refused either referral or enrollment in Project Link prenatally. As a result, these women received prenatal care but did not receive substance abuse treatment services during pregnancy.
After deciding on the research design, we prospectively identified and addressed factors potentially affecting the validity of the study. A primary concern focused on whether the pregnant and postpartum enrolled groups were sufficiently similar. Detailed comparisons performed on the characteristics of the two groups of women revealed the two groups to be remarkably similar. There were no significant differences in age, race, education, or income (Table 1) . Postpartum enrollees were more likely to be the head of the household and to have other children. Table 2 compares the substance abuse histories of the two groups. There were no significant differences in age of initiation of drug use, frequency of use, or relationships with partners or family members with drug problems. Those who enrolled while pregnant were more likely to have been in treatment previously and were more likely to admit difficulty in abstaining.
Both groups received equivalent prenatal care (Table 3 ). There was a tendency for the pregnant enrollees to have initiated care earlier; 54% started their care in the first trimester, compared with 39% of the postpartum group ( p ϭ 0.05) Although there was a significant difference in the mean number of prenatal visits (11.2 vs 8.1, p Ͻ 0.001), this difference was eliminated after correcting for gestational age at delivery. The postpartum enrollee group delivered 2 weeks earlier than the pregnant enrollee group and, therefore, missed the opportunity to have an additional one to two prenatal visits. Remarkably, even the women who chose not to enroll in Project Link during pregnancy made an average of eight prenatal visits.
Recognizing that individual differences and behavioral factors can affect outcome, the pregnancy outcome data were analyzed using both univariate and multivariate approaches. The pregnancy out- come variables selected for analysis were birth weight, gestational age, hospital length of stay, Apgar scores at 1 and 5 minutes, neonatal intensive care unit (NICU) admission, and infant toxicology status at birth. Although interrelated, these outcomes are known to be negatively impacted by intrauterine substance exposure and thus were chosen for inclusion in this study of birth outcomes as clear indicators of infant morbidity. Birth weight and gestational age were configured in a variety of ways. The percentage of newborns who were very low birth weight (Ͻ1500 gm), the percentage who were low birth weight (Ͻ2500 gm), and the average birth weight in grams were examined. Gestational age was reported in average weeks and as a proportion The multivariate model used ordinary least squares regression and logistic regression to control for individual characteristics that could affect outcome, including prior treatment involvement and prenatal care. The multivariate model specified that infant outcome (defined as the dependent variable listed above) is a function of characteristics of the mother, including her education (years), age (years), income (dollars per month), parity, alcohol use in the last 30 days (number of days of use in the last 30), cigarette use (yes/no), prior treatment history (yes/no), and her care-seeking behavior, including services received at Project Link (number of services), prenatal care (number of visits), enrollment in Project Link (during pregnancy or postpartum); infant outcome is also a function of characteristics of the newborn, including race (white, non-white) and sex (male/female). Logistic regression was used for those outcomes that were binary in nature. Length of stay variables were transformed to the common log because length of stay is not normally distributed.
RESULTS
Statistical analysis of birth outcomes demonstrated significant differences between the two groups of newborns in several important measures (Table 4) . Newborns of mothers enrolled during pregnancy had a mean birth weight of 3059 gm, which was 390 gm heavier than infants born to the postpartum enrollees ( p Ͻ 0.001). A higher percentage of newborns of postpartum enrollees were low birth weight (40.2% vs 19.5%, p Ͻ 0.001) and very low birth weight (10.4% vs 2.3%, p Ͻ 0.05) when compared with newborns of women who enrolled prenatally. Gestational age was almost 2 weeks shorter for those infants whose mothers enrolled postpartum, with a mean gestational age of 36.7 weeks, compared with 38.6 weeks for those infants whose mothers enrolled during pregnancy ( p Ͻ 0.001), and postpartum enrollees were much more likely to have had a preterm delivery (Ͻ37 weeks). Apgar scores at 1 and 5 minutes were significantly lower for the postpartum group. Mean duration of hospitalization for the infants of postpartum enrollees (16.9 days) was significantly longer than that seen for the infants of prenatal enrollees (10.6 days, p ϭ 0.01). Infants born to mothers who enrolled postpartum were 55% more likely ( p Ͻ 0.05) to be admitted to the NICU. Once admitted to the NICU, the newborns of postpartum enrollees had an average length of stay of 18.5 days, compared with 8.7 days for the pregnant enrollee group.
Regression analysis, which adjusted for individual differences known to affect outcome, showed that infants of prenatal enrollees were 418 gm heavier ( p Ͻ 0.001), approximately one-third as likely to be born low birth weight ( p Ͻ 0.01), and approximately one-tenth as likely to be born very low birth weight ( p Ͻ 0.05). They were, on average, 2 weeks older in terms of gestational age ( p Ͻ 0.001), onefifth as likely to be born before 37 weeks' gestation ( p Ͻ 0.001), and one-half as likely to be admitted to the NICU ( p Ͻ 0.05). The postpartum enrollees were more likely to have infants whose toxicology screens were positive (57.5% vs 21.8%, p Ͻ 0.01, Table 4 ).
DISCUSSION
Although the harmful effects of drug use during pregnancy are well recognized, the problem of perinatal substance abuse is a complex one with no simple solution. Women who use drugs during pregnancy are more likely to have a variety of adverse perinatal outcomes than women who do not. To what degree these adverse outcomes are physiologically related to drug exposure is difficult to determine, because these women's lives are often complicated by numerous factors known to be associated with poor pregnancy outcome (e.g., poor nutrition, anemia, inadequate social support, poor general health, and sexually transmitted infections). Many have long-standing addictions, having initiated their drug-taking behaviors as pre-adolescents. Most have been the victims of physical and/or sexual abuse and emotional trauma. Attempts to study the effectiveness of substance abuse treatment interventions on improving the outcome of pregnancy reflect the complexity of the problem of perinatal addiction. Complicating research efforts is the ethical problem related to randomization of pregnant addicts into treatment/nontreatment groups. Our study approached this problem by comparing the birth outcomes of women who received substance abuse treatment concurrent with prenatal care with similar women who received prenatal care at the same institution but did not avail themselves of substance abuse treatment services until after delivery. Every effort was made to determine the comparability of these two groups. We believe the groups are similar enough to support a fair comparison. The demographic, socioeconomic, and substance abuse profiles of the two groups, presented in Tables 1 and 2 , show very few differences, none of which are likely to have a significant impact on neonatal outcome. Both groups received equivalent prenatal care, and all patients delivered at the same hospital. Nevertheless, despite our finding that the two groups were similar in demographics and substance abuse history, multivariate analyses designed to control for individual differences revealed that the newborns of the prenatal enrollee group fared significantly better on most outcome parameters.
Using patient self-reported drug use and voluntary enrollment introduces a potential for bias. It is, unfortunately, a bias with which most studies of prenatal substance abuse must contend because of the legal and ethical considerations surrounding routine drug screening, randomization, and mandated reporting to child protective service agencies. Despite the limitations of self-reporting, the maternal interview, when conducted appropriately, has the greatest potential for obtaining comprehensive information on the type, amount, frequency, and duration of drug use during pregnancy. 13 Voluntary participation in substance abuse treatment enhances the reliability of patient self-reporting. In addition, the longitudinal nature of prenatal care offers women multiple opportunities to disclose substance use. It is not uncommon for women to admit to drug use (or to admit that they initially under-reported their drug use) after they have established a trusting relationship with one or more members of the health care team. 22, 23 All 174 patients in our study were self-reported substance abusers and, based on interview and questionnaire data, appeared to have remarkably similar drug abuse histories (Table 2) . Although there was no difference in the reported use of substances between the two groups, the pregnant enrollees were more likely to have been in treatment previously. This previous experience may have made it easier for them to recognize and accept the need for professional help. The slightly higher percentage of positive responses to many of the questions by the pregnant enrollees was not statistically significant and may reflect a stronger motivation of this group to be honest.
We acknowledge an element of self-selection bias within the total study group of 174 women, because the timing of enrollment (i.e., prenatally or postpartum) was a decision made by the women. A decision was made a priori, based on ethical concerns, not to withhold substance abuse treatment from any pregnant woman who requested it. Therefore, despite the similarities of the two groups, the group that enrolled during pregnancy was, for whatever reasons, motivated to seek treatment prenatally. One could hypothesize that the group that did not enter treatment until after delivery was composed of women with more serious addictions; perhaps they had failed treatment before, or were simply unwilling to commit to the program. However, one could also hypothesize that the women who enrolled during pregnancy had the more serious problems and recognized the fact that they needed professional help to address their dependency. Whatever the reasons for their differences in "treatment readiness," the group that was motivated to enroll during pregnancy may also have been motivated to alter other risk-taking behaviors or unhealthy lifestyles. Further research is needed to increase understanding of treatment readiness and the factors that motivate behavioral change and success in substance abuse treatment for the highly vulnerable population of pregnant substance-abusing women.
Although the substance abuse histories of the two groups were similar before enrollment, women who enrolled prenatally were less likely to deliver a newborn with a positive toxicology screen than the postpartum enrollees. More than half (57.5%) of the infants of the postpartum enrollees had positive toxicology screens at birth compared with 21.8% in the infants of pregnant enrollees. As stated previously, we reviewed all records of postpartum enrollees to determine whether a positive infant toxicology was the stimulus for referral to Project Link. In 84 of the 87 cases, the medical record clearly states that the woman was referred based on her substance abuse history. Indeed, in most cases, the referral to Project Link was made before the results of the infant's toxicology screen were available. This difference in positive infant toxicology screens at delivery, together with the results of random prenatal maternal drug screens, supports the conclusion that enrollment in Project Link helped many women decrease or abstain from illicit substances during pregnancy. Improvement in neonatal status in several additional dimensions, including higher mean birth weight, less low birth weight, less very low birth weight, less prematurity, higher Apgar scores, fewer NICU admissions, and shorter hospitalizations, supports diminished use of illicit drugs in the prenatal group.
The intervention from which the prenatal enrollees benefited was a multifaceted package of comprehensive substance abuse treatment services. Project services also addressed the numerous psychosocial disadvantages experienced by these women. Consequently, the improved neonatal outcomes could be the combined result of decreased maternal drug use, better prenatal nutrition, or a variety of other improvements in general maternal health status and lifestyle.
In summary, the experience of Project Link has demonstrated that providing easily accessible, gender-specific substance abuse treatment in conjunction with prenatal care can significantly improve birth outcomes for pregnant women who admit to illicit drug use and are willing to engage in treatment. Because the intervention was longitudinal and multifaceted, it is impossible to assign a cause and effect relationship to any single element of Project Link's program. Rather, the improved outcomes are due to participation in the comprehensive package of services provided. If women with substance abuse problems can be identified during pregnancy and motivated to enroll in a comprehensive substance abuse treatment program, they can reap not only the personal benefits of substance abuse treatment, but can have healthier babies as well. Pregnancy can be a window of opportunity during which substance-abusing women are encouraged to examine their lifestyles and health behaviors and to begin a process of long-term self improvement resulting in better lives for themselves and their children.
